View in EDS HTML Full Text PDF Full Text

Neuron‐glia interactions: Molecular basis of alzheimer's disease and applications of neuroproteomics.

Saved in:
Bibliographic Details
Title: Neuron‐glia interactions: Molecular basis of alzheimer's disease and applications of neuroproteomics.
Authors: Ibrahim, Abdallah Mohammad (AUTHOR), Pottoo, Faheem Hyder (AUTHOR), Dahiya, Ekta Singh (AUTHOR), Khan, Firdos Alam (AUTHOR), Kumar, J. B. Senthil (AUTHOR)
Source: European Journal of Neuroscience. Jul2020, Vol. 52 Issue 2, p2931-2943. 13p. 2 Diagrams, 2 Charts, 1 Graph.
Subjects: Alzheimer's disease, Molecular interactions, Mass spectrometry, Cognition disorders, Neuroglia, Vascular dementia, Senile dementia
Abstract: Neurodegenerative disorders present with progressive and irreversible degeneration of the neurons. Alzheimer's disease (AD) is one of the most common neurodegenerative disorders affecting 50 million people worldwide (2017), expected to be doubled every 20 years. Primarily affected by age, AD is the cause for old‐age dementia, progressive memory loss, dysfunctional thoughts, confusion, cognitive impairment and personality changes. Neuroglia formerly understood as "glue" of the brain neurons consists of macroglia (astrocytes and oligodendrocyte), microglia and progenitors NG2‐glia, and constitute a large fraction of the mammalian brain. The primary functions of glial cells are to provide neurons with metabolic and structural support in the healthy brain; however, they attain a "reactive" state from the "resting" state upon challenged with a pathological insult such as a neurodegenerative cascade. Failure or defects in their homoeostatic functions (i.e. concentration of ions, neurotransmitters) ultimately jeopardize neurons with excitotoxicity and oxidative stress. Moreover, the most common clinical outcome of AD is the cognitive impairment and memory loss, which are attributed mainly by the accumulation of Aβ. Failure of glial cells to remove the Aβ toxic proteins accelerates the AD progression. The rapidly emerging proteomic techniques such as mass spectrometry (MS), cross‐linking mass spectrometry, hydrogen deuterium trade mass spectrometry, protein foot printing and 2‐DGE combined with LC–MS/MS present wide array of possibilities for the identification of differentially expressed proteins in AD. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Neuroscience is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 144618731
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neuron‐glia interactions: Molecular basis of alzheimer's disease and applications of neuroproteomics.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Ibrahim%2C+Abdallah+Mohammad%22">Ibrahim, Abdallah Mohammad</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pottoo%2C+Faheem+Hyder%22">Pottoo, Faheem Hyder</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dahiya%2C+Ekta+Singh%22">Dahiya, Ekta Singh</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Khan%2C+Firdos+Alam%22">Khan, Firdos Alam</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kumar%2C+J%2E+B%2E+Senthil%22">Kumar, J. B. Senthil</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Neuroscience%22">European Journal of Neuroscience</searchLink>. Jul2020, Vol. 52 Issue 2, p2931-2943. 13p. 2 Diagrams, 2 Charts, 1 Graph.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Alzheimer's+disease%22">Alzheimer's disease</searchLink><br /><searchLink fieldCode="DE" term="%22Molecular+interactions%22">Molecular interactions</searchLink><br /><searchLink fieldCode="DE" term="%22Mass+spectrometry%22">Mass spectrometry</searchLink><br /><searchLink fieldCode="DE" term="%22Cognition+disorders%22">Cognition disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Neuroglia%22">Neuroglia</searchLink><br /><searchLink fieldCode="DE" term="%22Vascular+dementia%22">Vascular dementia</searchLink><br /><searchLink fieldCode="DE" term="%22Senile+dementia%22">Senile dementia</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Neurodegenerative disorders present with progressive and irreversible degeneration of the neurons. Alzheimer's disease (AD) is one of the most common neurodegenerative disorders affecting 50 million people worldwide (2017), expected to be doubled every 20 years. Primarily affected by age, AD is the cause for old‐age dementia, progressive memory loss, dysfunctional thoughts, confusion, cognitive impairment and personality changes. Neuroglia formerly understood as "glue" of the brain neurons consists of macroglia (astrocytes and oligodendrocyte), microglia and progenitors NG2‐glia, and constitute a large fraction of the mammalian brain. The primary functions of glial cells are to provide neurons with metabolic and structural support in the healthy brain; however, they attain a "reactive" state from the "resting" state upon challenged with a pathological insult such as a neurodegenerative cascade. Failure or defects in their homoeostatic functions (i.e. concentration of ions, neurotransmitters) ultimately jeopardize neurons with excitotoxicity and oxidative stress. Moreover, the most common clinical outcome of AD is the cognitive impairment and memory loss, which are attributed mainly by the accumulation of Aβ. Failure of glial cells to remove the Aβ toxic proteins accelerates the AD progression. The rapidly emerging proteomic techniques such as mass spectrometry (MS), cross‐linking mass spectrometry, hydrogen deuterium trade mass spectrometry, protein foot printing and 2‐DGE combined with LC–MS/MS present wide array of possibilities for the identification of differentially expressed proteins in AD. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of European Journal of Neuroscience is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=144618731
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/ejn.14838
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 2931
    Subjects:
      – SubjectFull: Alzheimer's disease
        Type: general
      – SubjectFull: Molecular interactions
        Type: general
      – SubjectFull: Mass spectrometry
        Type: general
      – SubjectFull: Cognition disorders
        Type: general
      – SubjectFull: Neuroglia
        Type: general
      – SubjectFull: Vascular dementia
        Type: general
      – SubjectFull: Senile dementia
        Type: general
    Titles:
      – TitleFull: Neuron‐glia interactions: Molecular basis of alzheimer's disease and applications of neuroproteomics.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ibrahim, Abdallah Mohammad
      – PersonEntity:
          Name:
            NameFull: Pottoo, Faheem Hyder
      – PersonEntity:
          Name:
            NameFull: Dahiya, Ekta Singh
      – PersonEntity:
          Name:
            NameFull: Khan, Firdos Alam
      – PersonEntity:
          Name:
            NameFull: Kumar, J. B. Senthil
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 07
              Text: Jul2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 0953816X
          Numbering:
            – Type: volume
              Value: 52
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: European Journal of Neuroscience
              Type: main
ResultId 1